Pfizer's Prevnar 20 Edges Closer To Infant Market, But Phase III Raises Some Questions

 
• By Jessica Merrill
babies
Pfizer hopes to get Prevnar 20 approved for infants • Source: Shutterstock

More from Clinical Trials

More from R&D